A diagnostic ‘cocktail,’ containing a single drop of blood, a dribble of water and a dose of DNA powder with gold particles, could one day lead to the treatment of the world’s leading diseases.
This homegrown brew is being developed by IBBME PhD student Kyryl Zagorovsky and Professor Warren Chan (IBBME), a Canada Research Chair in Nanobiotechnology, and a recent winner of the NSERC E.W.R. Steacie Memorial Fellowship.
“There’s been a lot of emphasis in developing simple diagnostics,” said Professor Chan. “The question is, how do you make it simple enough, portable enough?”
Professor Chan’s lab studies nanoparticles – in particular, the use of gold particles in sizes so small that they are measured in the nanoscale. He and his group are working on custom-designing nanoparticles to target and illuminate cancer cells and tumours, with the potential of one day being able to deliver drugs to cancer cells.
Zagorovsky’s rapid-diagnostic biosensor will allow technicians to test for multiple diseases at one time with one small sample, and with high accuracy and sensitivity. The biosensor relies upon gold particles in much the same vein as your average pregnancy test. With a pregnancy test, gold particles turn the test window red because the particles are linked with an antigen that detects a certain hormone in the urine of a pregnant woman.
“Gold is the best medium,” explained Professor Chan, “because it’s easy to see. It emits a very intense colour.”
Currently, scientists can target a particular disease by linking gold particles with DNA strands. When a sample containing the disease gene (e.g., Malaria) is present, it clumps the gold particles, turning the sample blue.
Rather than clumping the particles together, Zagorovsky immerses the gold particles in a DNA-based enzyme solution (DNA-zyme) that, when the disease gene is introduced, ‘snip’ the DNA from the gold particles, turning the sample red.
“It’s like a pair of scissors,” said Zagorovsky. “The target gene activates the scissors that cut the DNA links holding gold particles together.”
The advantage is that far less of the gene needs to be present for the solution to show noticeable colour changes, amplifying detection. A single DNA-zyme can clip up to 600 ‘links’ between the target genes.
Just a single drop from a biological sample such as saliva or blood can potentially be tested in parallel, so that multiple diseases can be tested in one sitting.
The Latest Bing News on:
- Rapid Antigen-based Testing for Respiratory Syncytial Viruson March 20, 2023 at 5:00 pm
For these reasons, it is the most widely used diagnostic test for RSV. RADTs are rapid immunoassays and are available from a variety of manufacturers in ready-made commercialized kits. With one ...
- Rapid Medical Diagnostic Device Market Size Report till 2029on March 17, 2023 at 10:33 am
Mar 17, 2023 (The Expresswire) -- "Rapid Medical Diagnostic Device Market" Insights 2023 By Applications (Cardio Metabolic Testing, Infectious ...
- SD Biosensor Eyes Global Expansion as Evaluations Find Rapid MDx System on Par With Competitionon March 15, 2023 at 11:41 am
The sample-to-answer system can multiplex up to 12 targets and can run both isothermal assays and RT-PCR with results in 30 minutes or 60 minutes, respectively.
- COVID-19 IgM/IgG Antibody Rapid Test Kits Market : Key Trends and Opportunities by State and Territory to 2028on March 13, 2023 at 7:33 pm
What is the COVID-19 IgM/IgG Antibody Rapid Test Kits market growth? COVID-19 IgM/IgG Antibody Rapid Test Kits Market Size is projected to Reach Multimillion USD by 2028, In comparison to 2023, at ...
- Biosensors Global Market Report 2023: Sector to Reach $49.8 Billion by 2030 at an 8% CAGRon March 13, 2023 at 5:30 pm
Moreover, the pandemic led to the rapid expansion of the biosensor industry due to an increase in the number of hospitals worldwide. Over the forecast period, technological advancements are ...
- Point-Of-Care Diagnostics Market Forecast To 2030 Industry Key Players, Share, Trend, Segmentation(Updated PDF)on March 13, 2023 at 1:15 am
Point-of-care Diagnostics Market 2030 Point of care diagnostics market is estimated to reach $55.3 Billion by 2030, growing at a CAGR of ...
- FREDsense Announces Rapid and Accurate Electrochemical Biosensor Solution for PFAS Detectionon February 23, 2023 at 7:22 am
The new FRED-PFAS system will integrate a PFAS-responsive biosensor solution into FREDsense’s field-based platform for rapid measurement. FREDsense’s patented electrochemical technology is ...
- Rapid quantitative screening of bispecific antibodies using Protein A and HIS1K biosensorson November 28, 2021 at 5:54 pm
They can now identify pools and clones with higher concentrations of bispecific antibodies. Higher throughput on the Octet system was achieved through rapid assay times - binding optimization in only ...
The Latest Google Headlines on:
[google_news title=”” keyword=”rapid-diagnostic biosensor” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Multiple disease testing
- Genetic test can guide treatment for blood cancer to prevent relapseon March 20, 2023 at 10:54 am
Scientists have found a new way to predict which patients with the blood cancer myeloma will benefit the most from a treatment often used to help keep the disease from coming back after a stem cell ...
- Cancer expert highlights advancements in treating multiple myelomaon March 20, 2023 at 9:20 am
March is Myeloma Awareness Month, and Sikander Ailawadhi, M.D., hematologist/oncologist at Mayo Clinic Comprehensive Cancer Center, shares details about new advancements in research leading to better ...
- Diseases Similar to MS (Multiple Sclerosis)on March 19, 2023 at 5:00 am
Nearly 1 million people in the U.S. have been diagnosed with multiple sclerosis, but research suggests that up to 1 in 5 people have been misdiagnosed. MS is an autoimmune disease that disrupts ...
- Can Pre-implantation Genetic Testing Tackle Multiple Miscarriages?on March 19, 2023 at 1:31 am
Preventing miscarriage With In-vitro fertilization (IVF), it is now possible to prevent miscarriage caused by genetic factors, Ajayi said, adding that with Pre-Implantation Genetic Testing (PGT ...
- Rapid Novor's Blood Test for Multiple Myeloma Monitoring is CLIA Certified for Clinical Use in the USon March 16, 2023 at 8:05 am
Rapid Novor Inc., the world's leader in mass spectrometry (MS)-based antibody protein sequencing, announced today that its diagnostic laboratory obtained the Clinical Laboratory Improvement Amendments ...
- Novel disease models for multiple myelomaon March 16, 2023 at 6:02 am
Multiple myelomas develop very ... not also carry modified Ikk2 did not develop the disease.” An important starting point for further tests Although the symptoms are similar – elevated calcium ...
- AI-Powered Cancer Monitoring Test Launched Across Europeon March 15, 2023 at 5:00 pm
“The last year has been incredibly exciting as we’ve solidified multiple global partnerships ... and accurate detection of cancer, monitor disease progression, and evaluate therapeutic efficacy. The ...
- New DNA tests predict your disease risk – are we ready for them?on March 14, 2023 at 12:41 pm
Polygenic tests can predict your risk of heart disease, diabetes and cancer, but some doctors worry about the consequences for healthcare systems and for us ...
- The 3 Best At-Home Lyme Disease Testson March 9, 2023 at 4:00 pm
The test will look for several markers of Lyme disease to ensure accuracy. You can also choose from multiple different panels of testing. Some of these panels, for example, look at T cells ...
- Multiple Myeloma Patients Find Clear Clinical and Emotional Benefit from MRD Testing. So How Do We Increase Awareness?on March 9, 2023 at 8:15 am
MRD testing offers extensive benefits. Its ability to precisely monitor disease status can help predict outcomes, inform disease management, and empower patients to better understand their disease or ...
The Latest Google Headlines on:
Multiple disease testing
[google_news title=”” keyword=”multiple disease testing” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]